HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lahouaria Hadri Selected Research

Ion Channels (Ion Channel)

1/2019Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lahouaria Hadri Research Topics

Disease

7Heart Failure
05/2019 - 03/2008
6Pulmonary Hypertension
06/2020 - 01/2015
6Vascular Remodeling
01/2020 - 07/2013
5Fibrosis (Cirrhosis)
03/2023 - 08/2011
5Inflammation (Inflammations)
03/2023 - 08/2011
5Hypoxia (Hypoxemia)
01/2022 - 01/2015
5Hypertrophy
05/2019 - 08/2011
4Pulmonary Arterial Hypertension
01/2022 - 07/2013
4Cardiomegaly (Heart Hypertrophy)
05/2019 - 06/2010
2COVID-19
01/2021 - 01/2021
2Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2020 - 01/2020
1Disease Progression
01/2021
1Inborn Genetic Diseases (Disease, Hereditary)
01/2021
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2020
1Ventricular Tachycardia
01/2019
1Hypertension (High Blood Pressure)
01/2018
1Atherosclerosis
01/2016
1Hyperaldosteronism (Conn Syndrome)
10/2014
1Right Ventricular Hypertrophy
07/2013
1Vascular System Injuries
07/2013
1Cardiovascular Diseases (Cardiovascular Disease)
07/2013
1Cicatrix (Scar)
03/2013
1Myocardial Infarction
03/2013
1Abdominal Aortic Aneurysm
09/2011
1Body Weight (Weight, Body)
08/2011
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
06/2010
1Heart Diseases (Heart Disease)
03/2009
1Neointima
09/2005

Drug/Important Bio-Agent (IBA)

8MonocrotalineIBA
01/2022 - 07/2013
5CalciumIBA
03/2023 - 01/2010
5Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA
07/2013 - 09/2005
3Semaxinib (SU5416)IBA
01/2022 - 01/2018
2Messenger RNA (mRNA)IBA
03/2023 - 08/2011
2Atrial Natriuretic Factor (ANF)IBA
05/2019 - 01/2015
2CalcineurinIBA
05/2019 - 06/2010
2CollagenIBA
01/2016 - 08/2011
2salicylhydroxamic acid (SHAM)IBA
03/2013 - 06/2010
1VaccinesIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Vasodilator Agents (Vasodilators)IBA
06/2020
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2020
1EnzymesIBA
01/2020
1Calcium-Transporting ATPases (Ca2+ ATPase)IBA
01/2020
1Cyclic AMP (AMP, Cyclic)IBA
01/2020
1Protein Isoforms (Isoforms)IBA
01/2020
1indium-bleomycinIBA
01/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020
1CatecholaminesIBA
05/2019
1Isoproterenol (Isoprenaline)FDA LinkGeneric
05/2019
1Ion Channels (Ion Channel)IBA
01/2019
1E 10 (E-10)IBA
01/2015
1RNA (Ribonucleic Acid)IBA
01/2015
1GalactosidasesIBA
07/2013
1Protein Phosphatase 1IBA
03/2013
1Green Fluorescent ProteinsIBA
09/2011
1Stromal Interaction Molecule 1IBA
08/2011
1Fibronectins (Fibronectin)IBA
08/2011
1ResistinIBA
08/2011
1Connective Tissue Growth FactorIBA
08/2011
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2010
1phospholambanIBA
03/2009
1Small Interfering RNA (siRNA)IBA
03/2009

Therapy/Procedure

10Therapeutics
08/2021 - 01/2010
2Pneumonectomy (Lung Volume Reduction)
01/2022 - 01/2019
1Ambulatory Care (Outpatient Care)
01/2021
1Precision Medicine
01/2021
1Nebulizers and Vaporizers (Inhaler)
10/2018
1RNAi Therapeutics
03/2009